bromfenac sodium
- Product NDC
- 68180-433
- 11-digit product format
- 681800433
- Labeler code
- 68180
- Product ID
- 68180-433_bdba6fae-8155-4d11-a0ec-a68e3c934ff9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bromfenac sodium
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA206027
- Marketing category
- ANDA
- Marketing start
- 2024-01-08
- Substance
- BROMFENAC SODIUM
- Active strength
- .805 mg/mL
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- bromfenac sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BROMFENAC SODIUM | .805 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8ECV571Y37 |
| Rxcui | 1375917 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-433-02 | bromfenac sodium | 3 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 3 | | 6 |
| 68180-433-02 | bromfenac sodium | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-433 | BROMFENAC SODIUM SOLUTION/ DROPS [LUPIN PHARMACEUTICALS, INC.] | 5 | Current NDC, 2 package rows | 20250309_26f3e5b3-a739-4b09-8046-e71ecb3a5a7b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68180-433-02 | 68180043302 | 1 BOTTLE, DROPPER in 1 CARTON (68180-433-02) / 3 mL in 1 BOTTLE, DROPPER | 2024-01-08 | No | No | Current |